The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Open accessAbstract
Assessment of Alzheimer's disease (AD)-related neurofibrillary pathology requires a procedure that permits a sufficient differentiation between initial, intermediate, and late stages. The gradual deposition of a hyperphosphorylated tau protein within select neuronal types in specific nuclei or areas is central to the disease process. The staging of AD-related neurofibrillary pathology originally described in 1991 was performed on unconventionally thick sections (100 mum) using a modern silver technique and reflected the progress of the disease process based chiefly on the topographic expansion of the lesions. To better meet the demands of routine laboratories this procedure is revised here by adapting tissue selection and processing to the needs of paraffin-embedded sections (5-15 mum) and by introducing a robust immunoreaction (AT8) for hyperphosphorylated tau protein that can be processed on an automated basis. It is anticipated that this revised methodological protocol will enable a more uniform application of the staging procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of Aβ plaques and NFTs follows distinct regional progressions across brain regions as AD advances.”
From National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2012) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with the stereotypical hierarchical accumulation of NFTs along neural networks20,21”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They were categorized into the stage C of amyloid deposition and the stage VI of neurofibrillary degeneration, following the Braak's staging (13).”
From Microglia express ABI3 in the brains of Alzheimer's disease and Nasu-Hakola disease (2017) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“by definition, the primary visual cortex (V1 region) bears NFTs only in Braak NFT stage VI20,21”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“we rank ordered the five brain regions based on their known vulnerability to neurofibrillary degeneration20,21 (that is, EC > ITG > PFC > V2 > V1)”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“the distinguishing feature between Braak NFT stages V and VI is not just the presence of NFTs in the primary visual (V1), motor and sensory cortical areas, but more severe neurofibrillary degeneration21 and atrophy throughout the cortical mantle51”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [2]
In the citing paper
“We consider it to be an important clue that most brains from elderly human subjects show abnormalities that fall somewhere along particular continua of pathologic severity (60, 96-100).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Self-citationFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Self-citationHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
(1964) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,411
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Self-citation
Research works printed but not linked: 7
- Alzheimer A (1906) Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurolog Centralbl 23:1129–1136
- Bielschowsky M (1902) Die Silberimprägnation der Axenzylinder. Neurol Centralb 13:579–584
- Bielschowsky M (1903) Die Silberimprägnation der Neurofibrillen. Neurol Centralb 21:997–1006
- Bielschowsky M (1904) Die Silberimprägnation der Neurofibrillen. Einige Bemerkungen zu der von mir angegebenen Methode und den von ihr gelieferten Bildern. J Psychol Neurol 3:169–189
- Bielschowsky M (1905) Die Darstellung der Axenzylinder peripherischer Nervenfasern und der Axenzylinder zentraler markhaltiger Nervenfasern. Ein Nachtrag zu der von mir angegebenen Imprägnationsmethode der Neurofibrillen. J Psychol Neurol 4:228–231
- Bielschowsky M (1909) Eine Modifikation meines Silberimprägnations-verfahrens zur Darstellung der Neurofibrillen. J Psychol Neurol 12:135–137
- Duyckaerts C, He Y, Seilhean D, Delaère P, Piette F, Braak H, Hauw JJ (1994) Diagnosis and staging of Alzheimer’s disease in a prospective study involving aged individuals. Neurobiol Aging 15(Suppl 1):140–141
Cited by
Sorted by citations
Items 501–600 of 1,028
Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old
Robinson, J. L., Geser, F., Corrada, M. M., Berlau, D. J., Arnold, S. E., Lee, V. M.-Y., Kawas, C. H., & Trojanowski, J. Q. (2011) · Brain · doi:10.1093/brain/awr308 · Cited by 88
Gardner, R. C., Rubenstein, R., Wang, K., Korley, F. K., Yue, J. K., Yuh, E. L., Mukherje, P., Valadka, A. B., Okonkwo, D. O., Diaz-Arrastia, R. R., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5694 · Cited by 91
Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
Gómez, W., Morales, R., Maracaja‐Coutinho, V., Parra, V., & Nassif, M. (2020) · Aging · doi:10.18632/aging.102677 · Cited by 94
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.585833 · Cited by 92
Neuropathology of Dementia Disorders
Schneider, J. A. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001137 · Cited by 93
Jha, N. K., Jha, S. K., Kumar, D., Kejriwal, N., Sharma, R., Ambasta, R. K., & Kumar, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150379 · Cited by 90
Brenowitz, W. D., Keene, C. D., Hawes, S. E., Hubbard, R. A., Longstreth, W. T., Woltjer, R. L., Crane, P. K., Larson, E. B., & Kukull, W. A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.017 · Cited by 88
Molecular imaging in dementia: Past, present, and future
Laforce, R. J., Soucy, J., Sellami, L., Dallaire‐Théroux, C., Brunet, F., Bergeron, D., Miller, B. L., & Ossenkoppele, R. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2855 · Cited by 88
Quantitative structural MRI for early detection of Alzheimer's disease
McEvoy, L. K., & Brewer, J. B. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.162 · Cited by 90
The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
Nowrangi, M. A., & Rosenberg, P. B. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00001 · Cited by 87
The association between tau PET and retrospective cortical thinning in clinically normal elderly
LaPoint, M. R., Chhatwal, J. P., Sepulcre, J., Johnson, K. A., Sperling, R. A., & Schultz, A. P. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.05.049 · Cited by 84
Synaptic protein levels altered in vascular dementia
Sinclair, L. I., Tayler, H. M., & Love, S. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12215 · Cited by 86
Leroy, A., Landrieu, I., Huvent, I., Legrand, D., Codeville, B., Wieruszeski, J.-M., & Lippens, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149419 · Cited by 86
Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca++ dysregulation
Decker, J. M., Krüger, L., Sydow, A., Zhao, S., Frotscher, M., Mandelkow�, E., & Mandelkow, E. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0193-3 · Cited by 86
Slaets, S., Bastard, N. L., Martin, J., Sleegers, K., Broeckhoven, C. V., Deyn, P. P. D., & Engelborghs, S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130107 · Cited by 87
Antibodies inhibit transmission and aggregation of C9orf72 poly‐GA dipeptide repeat proteins
Zhou, Q., Lehmer, C., Michaelsen, M., Mori, K., Alterauge, D., Baumjohann, D., Schludi, M. H., Greiling, J., Farny, D., Flatley, A., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607054 · Cited by 89
Self-citationRNA Binds to Tau Fibrils and Sustains Template-Assisted Growth
Dinkel, P. D., Holden, M. R., Matin, N., & Margittai, M. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00453 · Cited by 85
Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice
Sahu, B., Mackos, A. R., Floden, A. M., Wold, L. E., & Combs, C. K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200919 · Cited by 92
APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory
Kerchner, G. A., Berdnik, D., Shen, J. C., Bernstein, J. D., Fenesy, M. C., Deutsch, G. K., Wyss-Coray, T., & Rutt, B. K. (2014) · Neurology · doi:10.1212/wnl.0000000000000154 · Cited by 86
Alzheimer’s Disease Neuropathological Comorbidities are Common in the Younger-Old
Beach, T. G., & Malek‐Ahmadi, M. H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201213 · Cited by 88
Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs
Attems, J., Quass, M., & Jellinger, K. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0146-9 · Cited by 84
Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases
Kovács, G. G., & Budka, H. (2010) · Clinical Neuropathology · doi:10.5414/npp29271 · Cited by 86
Inda, M. C., Joshi, S., Wang, T., Bolaender, A., Gandu, S. R., Koren, J., Yue, A., Taldone, T., Yan, P., Sun, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14082-5 · Cited by 89
Neuropathological assessment of the Alzheimer spectrum
Jellinger, K. A. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02232-9 · Cited by 85
Moore, K. B. E., Hung, T.-J., & Fortin, J. S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103487 · Cited by 93
Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
Faivre, É., & Hölscher, C. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt174 · Cited by 84
Increased CSF α‐synuclein levels in Alzheimer's disease: Correlation with tau levels
Slaets, S., Vanmechelen, E., Le Bastard, N., Decraemer, H., Vandijck, M., Martin, J., De Deyn, P. P., & Engelborghs, S. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.004 · Cited by 85
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals
Ighodaro, E. T., Abner, E. L., Fardo, D. W., Lin, A.-L., Katsumata, Y., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Neltner, J. H., Monsell, S. E., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621574 · Cited by 98
Janaway, B. M., Simpson, J. E., Hoggard, N., Highley, J. R., Forster, G., Drew, D., Gebril, O. H., Matthews, F. E., Brayne, C., Wharton, S. B., et al. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12062 · Cited by 86
Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V. K., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 89
Unraveling the complexity of human brain: Structure, function in healthy and disease states
Sultana, O. F., Bandaru, M., Islam, M. A., & Reddy, P. H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102414 · Cited by 92
Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression
Manuel, I., Román, E. G. D. S., Giralt, M. T., Ferrer, I., & Rodríguez‐Puertas, R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140492 · Cited by 82
Kuo, S., Tang, G., Louis, E. D., Ma, K., Babji, R., Balatbat, M., Cortes, E. P., Vonsattel, J., Yamamoto, A., Sulzer, D. L., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1108-7 · Cited by 83
Svedberg, M. M., Hall, H., Hellström‐Lindahl, E., Estrada, S., Guan, Z.-Z., Nordberg, A. K., & Långström, B. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.016 · Cited by 85
Fyn Kinase Controls Tau Aggregation In Vivo
Briner, A., Götz, J., & Polanco, J. C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108045 · Cited by 85
Tanei, Z., Saito, Y., Ito, S., Matsubara, T., Motoda, A., Yamazaki, M., Sakashita, Y., Kawakami, I., Ikemura, M., Tanaka, S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02233-8 · Cited by 88
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
Macedo, A. C., Tissot, C., Therriault, J., Servaes, S., Wang, Y.-T., Arias, J. F., Rahmouni, N., Lussier, F. Z., Vermeiren, M. R., Bezgin, G., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.265200 · Cited by 99
Pikkarainen, M., Hartikainen, P. H., & Alafuzoff, I. I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a1da2 · Cited by 82
Self-citationCherbuin, N., Réglade‐Meslin, C., Kumar, R., Jacomb, P. A., Easteal, S., Christensen, H. M., Sachdev, P. S., & Anstey, K. J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000229025 · Cited by 82
Vermeiren, Y., Dam, D. V., Aerts, T., Engelborghs, S., & Deyn, P. P. D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.031 · Cited by 83
Increased number of Purkinje cell dendritic swellings in essential tremor
Yu, M., Ma, K., Faust, P. L., Honig, L. S., Cortés, E., Vonsattel, J., & Louis, E. D. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03598.x · Cited by 82
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
Abreha, M. H., Dammer, E. B., Ping, L., Zhang, T., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · PROTEOMICS · doi:10.1002/pmic.201800108 · Cited by 82
APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles
Ferrari-Souza, J. P., Lussier, F. Z., Leffa, D. T., Therriault, J., Tissot, C., Bellaver, B., Ferreira, P. C. L., Malpetti, M., Wang, Y.-T., Povala, G., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade1474 · Cited by 81
Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex
Welikovitch, L. A., Carmo, S. D., Maglóczky, Z., Szocsics, P., Lőke, J., Freund, T. F., & Cuello, A. C. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1922-z · Cited by 84
Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer’s disease
Saiz-Sanchez, D., De la Rosa-Prieto, C., Ubeda-Banon, I., & Martinez-Marcos, A. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0771-3 · Cited by 79
Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease
Ekonomou, A., Savva, G. M., Brayne, C., Forster, G., Francis, P. T., Johnson, M. A., Perry, E. K., Attems, J., Somani, A., Minger, S. L., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.021 · Cited by 81
Higashi, S., Moore, D. J., Yamamoto, R., Minegishi, M., Sato, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., Hino, H., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b44ed8 · Cited by 81
Ghebremedhin, E., Rosenberger, A., Rüb, U., Vukšić, M., Berhe, T., Bickeböller, H., de Vos, R. A. I., Thal, D. R., & Deller, T. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d88e63 · Cited by 82
Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain
Kuwabara, H., Comley, R., Borroni, E., Honer, M., Kitmiller, K., Roberts, J., Gapasin, L., Mathur, A., Klein, G., & Wong, D. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.214437 · Cited by 72
In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
Tournier, B. B., Tsartsalis, S., Ceyzériat, K., Garibotto, V., & Millet, P. (2020) · Cells · doi:10.3390/cells9091941 · Cited by 79
SantaCruz, K. S., Sonnen, J. A., Pezhouh, M. K., Desrosiers, M. F., Nelson, P. T., & Tyas, S. L. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822e8ae9 · Cited by 79
Test-retest reproducibility for the tau PET imaging agent flortaucipir F 18.
Devous, M. D., Joshi, A. D., Navitsky, M., Southekal, S., Pontecorvo, M. J., Shen, H., Lu, M., Shankle, W. R., Seibyl, J. P., Marek, K., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.200691 · Cited by 79
Amyloid and tau PET demonstrate region-specific associations in normal older people
Lockhart, S. N., Schöll, M., Baker, S. L., Ayakta, N., Swinnerton, K. N., Bell, R. K., Mellinger, T. J., Shah, V. D., O’Neil, J. P., Janabi, M., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.051 · Cited by 80
Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
Ferrer, I., Aguiló, M., Carmona, M., Andrés‐Benito, P., Torrejón-Escribano, B., Garcia‐Esparcia, P., & del Rı́o, J. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00112 · Cited by 78
Diagnostic Accuracy of Amyloid versus FDG PET in Patients with Cognitive Impairment and Autopsy
Lesman‐Segev, O. H., Joie, R. L., Iaccarino, L., Lobach, I. V., Rosen, H. J., Seo, S. W., Janabi, M., Baker, S. L., Edwards, L., Pham, J. Q., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25968 · Cited by 82
Raji, C. A., Becker, J. T., Tsopelas, N. D., Price, J. C., Mathis, C. A., Saxton, J. A., Lopresti, B. J., Hoge, J. A., Ziolko, S. K., DeKosky, S. T., et al. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.05.005 · Cited by 81
Yoshida, K., Hata, Y., Kinoshita, K., Takashima, S., Tanaka, K., & Nishida, N. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1665-7 · Cited by 78
Regional Overlap of Pathologies in Lewy Body Disorders
Colom‐Cadena, M., Grau‐Rivera, O., Planellás, L., Cerquera‐Cleves, C., Morenas‐Rodríguez, E., Helgueta, S., Muñoz, L., Kulisevsky, J., Martı́, M. J., Tolosa, E. S., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx002 · Cited by 80
Janssen, B., Vugts, D. J., Wilkinson, S. M., Ory, D., Chalon, S., Hoozemans, J. J. M., Schuit, R. C., Beaino, W., Kooijman, E. J. M., van den Hoek, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24814-0 · Cited by 81
Sartori, M., Mendes, T., Desai, S., Lasorsa, A., Herledan, A., Malmanche, N., Mäkinen, P., Marttinen, M., Malki, I., Chapuis, J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02017-9 · Cited by 72
Brain arterial aging and its relationship to Alzheimer dementia
Gutierrez, J., Honig, L. S., Elkind, M. S. V., Mohr, J. P., Goldman, J. E., Dwork, A. J., Morgello, S., & Marshall, R. S. (2016) · Neurology · doi:10.1212/wnl.0000000000002590 · Cited by 77
Entorhinal cortex: a good biomarker of mild cognitive impairment and mild Alzheimer’s disease
Zhou, M., Zhang, F., Zhao, L., Jin, Q., & Dong, C. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0019 · Cited by 84
Sánchez‐Mejías, E., Nuñez‐Diaz, C., Sanchez-Varo, R. M., Gómez-Arboledas, Á., García‐León, J. A., Fernandez-Valenzuela, J. J., Mejias‐Ortega, M., Trujillo‐Estrada, L., Baglietto‐Vargas, D., Moreno‐González, I., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12785 · Cited by 79
A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
Zheng, J., Tian, N., Liu, F., Zhang, Y., Su, J., Gao, Y., Deng, M., Wei, L., Ye, J., Li, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00669-2 · Cited by 78
Dadar, M., Manera, A. L., Ducharme, S., & Collins, D. L. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.11.007 · Cited by 78
Danis, C., Dupré, E., Zejneli, O., Caillierez, R., Arrial, A., Bégard, S., Mortelecque, J., Eddarkaoui, S., Loyens, A., Cantrelle, F., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.009 · Cited by 75
Rabinovici, G. D., Knopman, D. S., Arbizu, J., Benzinger, T. L. S., Donohoe, K. J., Hansson, O., Herscovitch, P., Kuo, P. H., Lingler, J. H., Minoshima, S., et al. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.268756 · Cited by 87
Louis, E. D., Babij, R., Lee, M., Cortes, E. P., & Vonsattel, J. (2013) · Movement Disorders · doi:10.1002/mds.25629 · Cited by 78
Fujimi, K., Sasaki, K., Noda, K., Wakisaka, Y., Tanizaki, Y., Matsui, Y., Sekita, A., Iida, M., Kiyohara, Y., Kanba, S., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00169.x · Cited by 79
Olfactory dysfunction in the pathophysiological continuum of dementia
Bathini, P., Brai, E., & Auber, L. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100956 · Cited by 77
Irwin, D. J., Lleó, A., Xie, S. X., McMillan, C. T., Wolk, D. A., Lee, E. B., Van Deerlin, V. M., Shaw, L. M., Trojanowski, J. Q., & Grossman, M. (2017) · Annals of Neurology · doi:10.1002/ana.24996 · Cited by 67
Microglial activation occurs late during preclinical Alzheimer's disease
Streit, W. J., Braak, H., Del Tredici, K., Leyh, J., Lier, J., Khoshbouei, H., Eisenlöffel, C., Müller, W., & Bechmann, I. (2018) · Glia · doi:10.1002/glia.23510 · Cited by 98
Self-citationBryant, A. G., Li, Z., Jayakumar, R., Serrano‐Pozo, A., Woost, B., Hu, M., Woodbury, M. E., Wachter, A., Lin, G., Kwon, T., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0237-23.2023 · Cited by 84
Neuropathological findings in benign tremulous Parkinsonism
Selikhova, M. V., Kempster, P. A., Révész, T., Holton, J. L., & Lees, A. J. (2012) · Movement Disorders · doi:10.1002/mds.25220 · Cited by 79
Aging‐related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes
Ferrer, I., Aguiló, M., González, I. L., Lucena, D. D., Roig, A., Carmona, M., Llorens, F., Garcia‐Esparcia, P., Martínez-Maldonado, A., Frau‐Méndez, M. A., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12593 · Cited by 77
Balu, D. T., Pantazopoulos, H., Huang, C. C., Muszynski, K., Harvey, T. L., Uno, Y., Rorabaugh, J. M., Galloway, C. R., Botz-Zapp, C. A., Berretta, S., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104511 · Cited by 78
Shin, J., Lee, S., Kim, S. J., Kim, S., Cho, S., & Kim, Y.-B. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.013 · Cited by 76
Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approach
Louis, E. D., Kerridge, C. A., Chatterjee, D., Martuscello, R. T., Diaz, D. T., Koeppen, A. H., Kuo, S., Vonsattel, J., Sims, P. A., & Faust, P. L. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02043-7 · Cited by 76
Alternative splicing in Alzheimer’s disease
Biamonti, G., Amato, A. M., Belloni, E., Matteo, A. D., Infantino, L., Pradella, D., & Ghigna, C. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01360-x · Cited by 78
Gomes, L. A., Uytterhoeven, V., Lopez-Sanmartin, D., Tomé, S. O., Tousseyn, T., Vandenberghe, R. R., Vandenbulcke, M., Arnim, C. A. F. V., Verstreken, P., & Thal, D. R. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02251-6 · Cited by 77
Pathology of clinical and preclinical Alzheimer’s disease
Thal, D. R., Arnim, C. A. F. V., Griffin, W. S. T., Yamaguchi, H., Mrak, R. E., Attems, J., & Upadhaya, A. R. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0449-5 · Cited by 80
Lasagna‐Reeves, C. A., Sengupta, U., Castillo‐Carranza, D. L., Gerson, J. E., Guerrero‐Munoz, M. J., Troncoso, J. C., Jackson, G. R., & Kayed, R. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-56 · Cited by 78
Ayyadevara, S., Balasubramaniam, M., Parcon, P. A., Barger, S. W., Griffin, W. S. T., Alla, R., Tackett, A. J., Mackintosh, S. G., Petricoin, E. F., Zhou, W., et al. (2016) · Aging Cell · doi:10.1111/acel.12501 · Cited by 77
Shared Functions of Perirhinal and Parahippocampal Cortices: Implications for Cognitive Aging
Burke, S. N., Gaynor, L. S., Barnes, C. A., Bauer, R. M., Bizon, J. L., Roberson, E. D., & Ryan, L. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.001 · Cited by 78
den Haan, J., Morrema, T. H. J., Rozemüller, A. J. M., Bouwman, F. H., & Hoozemans, J. J. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0577-2 · Cited by 76
Das, R. C., Rauf, A., Akhter, S., Islam, M. N., Emran, T. B., Mitra, S., Khan, I. N., & Mubarak, M. S. (2021) · Molecules · doi:10.3390/molecules26123696 · Cited by 79
von E conomo neurones are selectively targeted in frontotemporal dementia
Santillo, A. F., Nilsson, C., & Englund, E. M. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12021 · Cited by 77
Uhrig, S., Hirth, N., Broccoli, L., von Wilmsdorff, M., Bauer, M., Sommer, C., Zink, M., Steiner, J. H., Frodl, T., Malchow, B., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.019 · Cited by 73
Kovács, G. G., Horváth, M., Majtényi, K., Lutz, M. I., Hurd, Y. L., & Keller, É. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.018 · Cited by 75
Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease
Phillips, J. S., Da Re, F., Dratch, L., Xie, S. X., Irwin, D. J., McMillan, C. T., Vaishnavi, S. N., Ferrarese, C., Lee, E. B., Shaw, L. M., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.008 · Cited by 74
Chibnik, L. B., White, C. C., Mukherjee, S., Raj, T., Yu, L., Larson, E. B., Montine, T. J., Keene, C. D., Sonnen, J. A., Schneider, J. A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.20 · Cited by 71
CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD
Blennow, K., Lucena, D. D., Zetterberg, H., Villar‐Piqué, A., Karch, A., Vidal, E., Hermann, P., Schmitz, M., Ferrer, I., Zerr, I., et al. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320155 · Cited by 78
microRNAs as early biomarkers of Alzheimer’s disease: a synaptic perspective
Siedlecki-Wullich, D., Miñano-Molina, A. J., & Rodríguez-Álvarez, J. (2021) · Cells · doi:10.3390/cells10010113 · Cited by 76
Fan, Y., Nirujogi, R. S., Garrido, A., Ruiz‐Martínez, J., Bergareche‐Yarza, A., Rezola, E. M., Vinagre‐Aragón, A., Croitoru, I. M., Pagola, A. G., Markinez, L. P., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02325-z · Cited by 73
ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease
Patro, S., Ratna, S., Yamamoto, H. A., Ebenezer, A. T., Ferguson, D. S., Kaur, A., McIntyre, B. C., Snow, R., & Solesio, M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011185 · Cited by 76
Moloney, C. M., Labuzan, S. A., Crook, J. E., Siddiqui, H., Castanedes‐Casey, M., Lachner, C., Petersen, R. C., Duara, R., Graff‐Radford, N. R., Dickson, D. W., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12749 · Cited by 76
Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults
Dong, Y., Li, Y., Liu, K., Han, X., Liu, R., Ren, Y., Cong, L., Zhang, Q., Hou, T., Song, L., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12777 · Cited by 74
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Lista, S., González‐Domínguez, R., López‐Ortiz, S., González‐Domínguez, Á., Menéndez, H., Martín-Hernández, J., Lucía, A., Emanuele, E., Centonze, D., Imbimbo, B. P., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101987 · Cited by 76
Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico‐pathological insights
Rüb, U., Bürk, K., Timmann, D., den Dunnen, W. D., Seidel, K., Farrag, K., Brunt, E., Heinsen, H., Egensperger, R., Bornemann, A., et al. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01259.x · Cited by 72
Upadhaya, A. R., Lungrin, I., Yamaguchi, H., Fändrich, M., & Thal, D. R. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01306.x · Cited by 75
Metadata
- Authors
- Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K.
- Affiliations
- Goethe University Frankfurt (DE)
- Kuopio University Hospital (FI)
- Institut für Neuropathologie (DE)
- Corresponding author
- Braak, Heiko
- Venue
- Acta Neuropathologica
- Published
- 2006-08-12
- Volume
- 112
- Issue
- 4
- Pages
- 389-404
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3906709
- OpenAlex
- W2093650784
- Cited by
- 3,172
- References
- 101
- Citations by year
- 2026: 218 · 2025: 259 · 2024: 334 · 2023: 254 · 2022: 251 · 2021: 261 · 2020: 228 · 2019: 205 · 2018: 157 · 2017: 135 · 2016: 140 · 2015: 118 · 2014: 134 · 2013: 95 · 2012: 77
- FWCI
- 34.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (LSHM-CT-2004-503039)
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary pathology, disease staging, AT8 antibody, immunocytochemistry, paraffin sections, silver staining
- MeSH terms
- Alzheimer Disease, Humans, Immunohistochemistry, Amyloid beta-Peptides, Paraffin Embedding, Tissue Fixation, Neurofibrillary Tangles, tau Proteins, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
